Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema (Q34574399)

3 August 2017

1 reference

title

Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema (English)

1 reference

3 August 2017

1

William H Frishman

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

American Journal of Cardiology

3 August 2017

published in

1 reference

3 August 2017

volume

89

1 reference

3 August 2017

issue

6A

1 reference

3 August 2017

page(s)

18D-25D

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

3 August 2017

1 reference

Recognition of systolic hypertension for hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Clinical Advisory Statement. Importance of systolic blood pressure in older Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Impact of high-normal blood pressure on the risk of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

NSAIDs and blood pressure. Clinical importance for older patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Blood pressure, stroke, and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Renal effects of COX-2-selective inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Effects of celecoxib and naproxen on renal function in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

The coxibs, selective inhibitors of cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

High-normal blood pressure--more "high" than "normal"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Angiotensin II attenuates renal cortical cyclooxygenase-2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Physiological regulation of cyclooxygenase-2 in the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Aspirin lowers blood pressure in patients with renovascular hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

[The physiological role of P450-derived arachidonic acid metabolites]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Abnormal pressure-natriuresis in hypertension: role of cytochrome P450 metabolites of arachidonic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

The role of the cytochrome P450-dependent metabolites of arachidonic acid in blood pressure regulation and renal function: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Nonsteroidal anti-inflammatory drugs and blood pressure in an elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902233-6

10.1016/S0002-9149(02)02233-6

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference